Your browser doesn't support javascript.
loading
Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.
Royo, Felix; Zuñiga-Garcia, Patricia; Torrano, Verónica; Loizaga, Ana; Sanchez-Mosquera, Pilar; Ugalde-Olano, Aitziber; González, Esperanza; Cortazar, Ana R; Palomo, Laura; Fernández-Ruiz, Sonia; Lacasa-Viscasillas, Isabel; Berdasco, Maria; Sutherland, James D; Barrio, Rosa; Zabala-Letona, Amaia; Martín-Martín, Natalia; Arruabarrena-Aristorena, Amaia; Valcarcel-Jimenez, Lorea; Caro-Maldonado, Alfredo; Gonzalez-Tampan, Jorge; Cachi-Fuentes, Guido; Esteller, Manel; Aransay, Ana M; Unda, Miguel; Falcón-Pérez, Juan M; Carracedo, Arkaitz.
Afiliação
  • Royo F; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Zuñiga-Garcia P; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Spain.
  • Torrano V; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Loizaga A; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Sanchez-Mosquera P; Department of Urology, Basurto University Hospital, Bilbao, Spain.
  • Ugalde-Olano A; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • González E; Department of Pathology, Basurto University Hospital, Bilbao, Spain.
  • Cortazar AR; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Palomo L; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Fernández-Ruiz S; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Lacasa-Viscasillas I; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Berdasco M; Department of Urology, Basurto University Hospital, Bilbao, Spain.
  • Sutherland JD; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Barrio R; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Zabala-Letona A; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Martín-Martín N; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Arruabarrena-Aristorena A; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Valcarcel-Jimenez L; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Caro-Maldonado A; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Gonzalez-Tampan J; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Cachi-Fuentes G; Department of Urology, Basurto University Hospital, Bilbao, Spain.
  • Esteller M; Department of Urology, Basurto University Hospital, Bilbao, Spain.
  • Aransay AM; Cancer Epigenetics and Biology Program, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
  • Unda M; CIC bioGUNE, Bizkaia Technology Park, Biscay, Spain.
  • Falcón-Pérez JM; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (Ciberehd), Spain.
  • Carracedo A; Department of Urology, Basurto University Hospital, Bilbao, Spain.
Oncotarget ; 7(6): 6835-46, 2016 Feb 09.
Article em En | MEDLINE | ID: mdl-26771841
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Caderinas / Vesículas Extracelulares Limite: Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / Caderinas / Vesículas Extracelulares Limite: Humans / Male Idioma: En Revista: Oncotarget Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Espanha